US FDA to propose new rule, guidance on e-submission of all drug study data
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration plans to propose by mid-2012 a new rule that would require drug companies to use an electronic format to submit all the study data that they include in their marketing applications1,2.